Medication therapy of endometriosis: chances and prospects

Abstract

Endometriosis is one of the most common women's diseases nowadays, commonly encountered by clinicians and researchers all over the world due to variability of assumed mechanisms of pathogenesis, a wide range of clinical manifestations (from asymptomatic forms to rather severe conditions), chronic progredient course, and particularly negative impact on physical condition, psychological status, social well-being and reproductive function of female patients [6, 11, 21, 23, 38]. Diversity of clinical signs and topography of the disease led to emergence of a wide range of treatment algorithms and necessitated the need for individual therapeutic approach [14, 22]. The majority of experts, while considering endometriosis to be a proliferative disease requiring surgical intervention to remove the spot, recognize combination treatment to be the method of choice. The method ideally provides for surgery (radical or organ-preserving) and long-term follow-up medication therapy taking into account the age and reproductive future of the patient [34, 42].

Keywords

• эндометриоз
• репродуктивная функция
• гестагены
• визанна
• endometriosis
• reproductive function
• gestagens
• visanne